Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

News > Portugal & Spain

Find below news from the Portugal and Spain. Listed are news about these countries as well as from organisations located there.

Total search results: 395 | Ordered by Date (descending)
next pagenext page 1 2 3 4  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
PharmaMar S.A.. (10/4/16). "Press Release: PharmaMar and Boryung Pharm Sign a Licensing Agreement for Aplidin (plitidepsin) in Korea". Madrid. 2016-10-04
Eurofins Scientific. (9/30/16). "Press Release: Eurofins Expands Its Clinical Diagnostic Footprint with the Acquisition of Megalab in Spain". 2016-09-30
Oryzon Genomics S.A.. (9/26/16). "Press Release: Oryzon Closes € 5.3 Million (6 M USD) in Additional Debt Financing". Barcelona & Cambridge, MA. 2016-09-26
PharmaMar S.A.. (9/22/16). "Press Release: PharmaMar Submits MAA to EMA for Aplidin for the Treatment of Multiple Myeloma". Madrid. 2016-09-22
Orchard Therapeutics Ltd.. (9/21/16). "Press Release: Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy at September 2016 ESID and ESGCT Congresse 2016-09-21
Bruker Corporation. (9/7/16). "Press Release: Bruker Signs Agreement to Acquire Oncovision’s Preclinical PET Imaging Business". New York, NY. 2016-09-07
Oryzon Genomics S.A.. (9/1/16). "Press Release: Oryzon Genomics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference and at BioPharm America 2016". Barcelona & Cambridge, MA. 2016-09-01
PharmaMar S.A.. (8/2/16). "Press Release: PharmaMar Initiates a Pivotal Phase III ATLANTIS Study with PM1183 in Combination with Doxorubicin in Patients with Small Cell Lung Cancer". Madrid. 2016-08-02
Bayer AG. (6/28/16). "Press Release: Bayer’s Regorafenib Significantly Improves Overall Survival in Patients with Unresectable Liver Cancer [Not intended for U.S. and UK Media]". Berlin. 2016-06-28
Minoryx Therapeutics S.L.. (6/14/16). "Press Release: Minoryx Therapeutics appoints Dr. Uwe Meya as Chief Medical Officer". Mataró, Barcelona. 2016-06-14
Biocat. (5/19/16). "Press Release: IDP Pharma Raises €2 Millions to Develop IDP Protein Drugs". Basel. 2016-05-19
Qiagen N.V.. (5/19/16). "Press Release: Qiagen Bioinformatics Continues to Set the Standard with Hereditary Disease Solution. Expanded Offering Provides Highly Accurate Clinical Sequence Data Interpretation". Barcelona. 2016-05-19
Peptomyc S.L.. (5/19/16). "Press Release: Peptomyc Completes Seed Funding of €1M". Basel. 2016-05-19
Oryzon Genomics S.A.. (5/18/16). "Press Release: Oryzon to Extend Its R&D Collaboration on ORY-1001 until March 2017". Barcelona & Cambridge, MA. 2016-05-18
Oryzon Genomics S.A.. (5/12/16). "Press Release: Oryzon Reports First Quarter 2016 Financial Results and Corporate Update". Barcelona & Cambridge, MA. 2016-05-12
Grifols S.A.. (5/5/16). "Press Release: Grifols' Revenues Increase by +5.6% to Euros 959 Million, Driven by Growth of +10.9% for the Bioscience Division". Barcelona. 2016-05-05
Oryzon Genomics S.A.. (5/4/16). "Press Release: Oryzon Closes € 10.5 Million (12.1 M USD) Debt Financing". Barcelona & Cambridge, MA. 2016-05-04
STAT-Diagnostica & Innovation S.L.. (4/11/16). "Press Release: STAT-Diagnostica Announces 25 Million Euros in Series C Financing Led by Gilde Healthcare. Funding Will Be Used to Accelerate Go-to-Market Strategy". Barcelona. 2016-04-11
Metabolon, Inc.. (3/29/16). "Press Release: Metabolon and Synlab Group Form Commercialization Collaboration for Quantose IR Diagnostic". Research Triangle Park, NC. 2016-03-29
Grünenthal GmbH. (3/15/16). "Press Release: Grünenthal Group to Acquire Almirall de Mexico, S.A. de C.V.". Aachen & Mexico City. 2016-03-15
Grifols S.A.. (3/8/16). "Press Release: Industrial Investments Plan 2016–2021 for the Bioscience Division. Grifols Will Invest USD 360M to Expand Its Manufacturing Capacities for Plasma-derived Therapies". Barcelona. 2016-03-08
Grifols S.A.. (2/29/16). "Press Release: Grifols' Revenues Grow by 17.3% to Euros 3,935 Million, and Net Profit Grows by 13.2% Reaching Euros 532 Million". Barcelona. 2016-02-29
Onxeo S.A.. (2/22/16). "Press Release: Onxeo Expands Collaborations to Advance Development Program of Key Orphan Oncology Assets in Combination with Immuno-oncology Agents". Paris & Copenhagen. 2016-02-22
Biocat. (1/27/16). "Press Release: GoodGut Gets €615,000 to Research Ways to Detect Colon Cancer and Crohn’s". 2016-01-27
Aelix Therapeutics S.L.. (1/11/16). "Press Release: Aelix Therapeutics Completes Series A Funding of €11.5m ($12.7m) for Therapeutic HIV Vaccine". Barcelona. 2016-01-16
Ergomed plc. (12/16/15). "Press Release: Ergomed plc Provides Update on Co-Development Partnerships". Guildford. 2015-12-16
Thermo Fisher Scientific Inc.. (12/15/15). "Press Release: Thermo Fisher Scientific Awards 2015 Attune NxT Flow Cytometry Grant to California Cancer Researcher". Albany, NY. 2015-12-15
Oryzon Genomics S.A.. (12/10/15). "Press Release: Oryzon Genomics Announces Listing on Madrid Stock Exchange". Barcelona & Cambridge, MA. 2015-12-10
Almirall S.A.. (11/30/15). "Press Release: Almirall Reaches an Agreement to Acquire 100% of Poli Group". Barcelona. 2015-11-30
Sygnis AG. (11/17/15). "Press Release: Sygnis AG Plans to Issue New Shares to Finance further Growth and Commercialization of Proprietary Product Portfolio [Not for US, CA, JP and AU] NOT FOR DISTRIBUTION, PUBLICATION, OR TRANSMISSION IN USA, CANADA, 2015-11-17
PharmaMar S.A.. (11/2/15). "Press Release: PharmaMar Begins Trading on Spanish BME Stock Exchange. PharmaMar Trading Following a Merger with Zeltia". Madrid. 2015-11-02
Mind the Byte S.L.. (10/29/15). "Press Release: Mind the Byte Concludes the Biggest Round of Biotech Crowd-equity in Spain, Achieving €234,310 through the Crowdcube Platform". Barcelona. 2015-10-29
Grifols S.A.. (10/28/15). "Press Release: Grifols Agrees Long Term Loan with the European Investment Bank". Barcelona. 2015-10-28
Oryzon Genomics S.A.. (10/27/15). "Press Release: Oryzon Raises $19 Million in Private Placement to Advance Therapeutic Programs". Barcelona & Cambridge, MA. 2015-10-27
Novartis AG. (10/21/15). "Press Release: Novartis Broadens Immuno-oncology Pipeline with Acquisition of Admune Therapeutics and Licensing Agreements with XOMA and Palobiofarma". Basel. 2015-10-21
Grifols S.A.. (10/22/15). "Press Release: Grifols Official Opening of the Bioscience Division New Worldwide Operations Facility in Ireland". Barcelona & Dublin. 2015-10-15
Grupo Uriach. (10/15/15). "Press Release: Uriach Acquires Laborest". Barcelona. 2015-10-15
Minoryx Therapeutics S.L.. (10/14/15). "Press Release: Minoryx Therapeutics Completes Series A Funding of €19.4M ($21.7M)". Mataró, Barcelona. 2015-10-14
Servier. (10/5/15). "Press Release: Servier Offers Its Expertise in Industrial R&D, Chemical Synthesis and Pharmaceutical Manufacturing to Partners". 2015-10-05
Sophia Genetics S.A.. (9/25/15). "Press Release: Welcome to Our 11 New Partners !". 2015-09-25
Zeltia S.A.. (9/15/15). "Press Release: PharmaMar Opens New Affiliate in UK". Madrid. 2015-09-15
Laboratoris Sanifit S.L.. (9/8/15). "Press Release: Sanifit Raises €36.6M ($41.3M) in Series C Financing Round". Berlin. 2015-09-08
Forbion Capital Partners. (9/8/15). "Press Release: Forbion Invests in Sanifit’s €36.6m ($41m) Series C Financing Round". Naarden. 2015-09-08
Bruker Corporation. (9/3/15). "Press Release: Bruker Introduces Four Next-generation Preclinical Imaging Systems at WMIC 2015 New Breakthrough PET/CT and PET/MRI Systems Change Performance Paradigm". Honolulu. 2015-09-03
Zeltia S.A.. (9/1/15). "Press Release: Pharmaceutical Council Recommends Approval of Yondelis (trabectedin) in Japan". Madrid. 2015-09-01
Zeltia S.A.. (8/20/15). "Press Release: PharmaMar Announces License Agreement with Specialised Therapeutics Australia Pty for Aplidin (plitidepsin) in Oncology". Madrid. 2015-08-20
Zeltia S.A.. (7/31/15). "Press Release: PharmaMar Passes the U.S. FDA Manufacturing Inspection for Yondelis Active Ingredient". Madrid. 2015-07-31
TiGenix N.V.. (7/30/15). "Press Release: TiGenix Expands Pipeline and Enters the Cardiology Field with Clinical-stage Company Acquisition". Leuven. 2015-07-30
Sophia Genetics S.A.. (7/29/15). "Press Release: Game Changing Partnership between Sophia Genetics and Genycell Biotech to Dramatically Expand Patients’ Access to Genetic Diagnosis in the Iberian Peninsula". Lausanne. 2015-07-29
Almirall S.A.. (7/29/15). "Press Release: Almirall Closes $15 Million Strategic Investment in Suneva Medical". Barcelona. 2015-07-29
Zeltia S.A.. (7/28/15). "Press Release: Grupo Zeltia Reports First Half 2015 Financial Results". Madrid. 2015-07-28
Zeltia S.A.. (7/23/15). "Press Release: PharmaMar Announces License Agreement with TTY Biopharm for Aplidin (plitidepsin) in Hematological Cancers". Madrid. 2015-07-23
Zeltia S.A.. (7/22/15). "Press Release: Genomica and the Foundation for Excellence and Quality in Oncology Announce a Framework Agreement for Collaboration in Oncology". Madrid. 2015-07-22
Sophia Genetics S.A.. (7/16/15). "Press Release: Cutting Edge Spanish Genetic Laboratories Join Data Driven Medicine European Movement". Lausanne. 2015-07-16
Zeltia S.A.. (6/29/15). "Press Release: PharmaMar Initiates the Phase III Study CORAIL for the Anticancer Agent PM1183 in Patients with Platinum-resistant Ovarian Cancer". Madrid. 2015-06-29
MedDay Pharmaceuticals S.A.S.. (6/19/15). "Press Release: MedDay Reports Additional Positive Data of Its Pivotal Phase III Study with MD1003 in Patients with Progressive Multiple Sclerosis". Paris. 2015-06-19
Vall d’Hebron Institute of Oncology (VHIO). (6/10/15). "Press Release: Vall d’Hebron Institute of Oncology and AstraZeneca Form an Oncology Alliance". 2015-06-10
BEAM Alliance. (6/9/15). "Press Release: Launch of the BEAM Alliance – Europe’s Combined Action against Antimicrobial Resistance. Biotechs from Europe Innovating in Anti-microbial Resistance". 2015-06-09
Sygnis AG. (5/13/15). "Press Release: Sygnis AG Announces Genetrix S.L. Has Taken Over All Shares from Genetrix Life Sciences AB to Become New Majority Shareholder". Madrid & Heidelberg. 2015-05-13
3P Biopharmaceuticals S.L.. (5/5/15). "Press Release: 3P Biopharmaceuticals Acquires a Mass Spectrometer". 2015-05-05
Phenomenex, Inc.. (5/1/15). "Press Release: Phenomenex Acquires Micron Analitica S.A. in Spain to Expand Global Presence". Torrance, CA. 2015-05-01
3P Biopharmaceuticals S.L.. (4/23/15). "Press Release: 3P Biopharmaceuticals Produces a Cellular Drug for the First Clinical Trial of Acute Myocardial Infarction with Allogeneic Cardiac Stem Cells". 2015-04-23
Ability Pharmaceuticals S.L.. (4/7/15). "Press Release: Ability Pharmaceuticals Receives Positive Opinion from EMA for Orphan Drug Status of ABTL0812 in Pediatric Cancer Neuroblastoma". Barcelona. 2015-04-07
Biofrontera AG. (3/25/15). "Press Release: Biofrontera Starts Sales and Marketing of Ameluz in Spain. Key Account Manager Transfers from Allergan to Biofrontera". Leverkusen. 2015-03-25
Ingeniatrics. (03/10/2015). "Press Release: The European Molecular Biology Laboratory Acquires the Ingeniatrics’ Cellena Bio-encapsulation Device". 2015-03-10
Ingeniatrics. (03/10/2015). "Press Release: Ingeniatrics Begins to Monetize Their more than 70 Patents". 2015-03-10
Enantia S.L.. (3/9/15). "Press Release: Enantia’s Cocrystallization Technology Endorsed by Global Partnership". 2015-03-09
Grifols S.A.. (3/4/15). "Press Release: Grifols to Make a Major Equity Investment in Alkahest". Barcelona. 2015-03-04
Zeltia S.A.. (2/26/15). "Press Release: Zeltia's Board of Directors Will Propose to the Next Shareholders' Meeting that Pharma Mar Merge with and Absorb Its Parent Company, Zeltia. The Board of Directors Will also Request that Pharma Mar Seek an IPO in 2015-02-26
Zeltia S.A.. (2/26/15). "Press Release: Grupo Zeltia Net Attributable Profit Amounted to 13 Million Euro in 2014 (+16%). Group Total Revenues Amounted to 178 Million Euro (+8%).". Madrid. 2015-02-26
Grifols S.A.. (2/26/15). "Press Release: Grifols Achieves a Record Net Profit of 470.3 Million Euros with Growth of 36.1% in 2014". Barcelona. 2015-02-26
Almirall S.A.. (2/23/15). "Press Release: Almirall Full-year 2014 Results – in Line with Guidance". Barcelona. 2015-02-23
Merck KGaA. (2/20/15). "Press Release: Merck Serono and Sysmex Inostics Announce First Liquid Biopsy RAS Biomarker Testing Center Opens. Important Milestone for mCRC Patients". Darmstadt & Barcelona. 2015-02-20
Grifols S.A.. (2/18/15). "Press Release: Grifols PhocusRx Certified DIACAP Compliant". Los Angeles. 2015-02-18
Grifols S.A.. (2/5/15). "Press Release: SIPPET Study on Inhibitors in Hemophilia A. Interim Analysis Confirms the Original Hypothesis". San Francisco. 2015-02-05
Zeltia S.A.. (2/3/15). "Press Release: U.S. FDA Grants Priority Review to Yondelis NDA for Advanced Soft-tissue Sarcoma". Madrid. 2015-02-03
Grifols S.A.. (1/27/15). "Press Release: Grifols Partners with Johnston County Educators to Develop Science Program". Clayton, NC. 2015-01-27
AB Sciex. (1/22/15). "Press Release: European Reference Laboratory Improves Accuracy of Pesticide Detection in Food with AB SCIEX Mass Spectrometry Instrumentation". Warrington. 2015-01-22
Sygnis AG. (01/21/15). "Press Release: Sygnis Signs Distribution Agreement with BioNova Cientifica, for its Innovative TruePrime Single Cell WGA Kit in Spain". Madrid. 2015-01-21
Zeltia S.A.. (1/13/15). "Press Release: PharmaMar Will Start a Phase III Study of PM1183 in Combination with Doxorubicin in Relapsed SCLC". Madrid. 2015-01-13
Grifols S.A.. (1/2/15). "Press Release: Grifols Receives FDA Approval for its New Purification Plant to Produce Gamunex in Los Angeles". Barcelona. 2015-01-02
Zeltia S.A.. (12/2/14). "Press Release: Zeltia Announces that Its Board of Directors Has Approved a Strategy to Explore Merging PharmaMar and Zeltia in Advance of a Listing Request in the US". Madrid. 2014-12-02
Biocat. (11/27/14). "Press Release: Phyture Biotech Signs Distribution Contract, Moving into 11 Markets in Europe and Latin America. InKemia IUCT Group Holds 21% of the Company’s Equity". 2014-11-27
Zeltia S.A.. (11/25/14). "Press Release: PharmaMar Announces that Its Partner Janssen Has Submitted a New Drug Application for Yondelis to the U.S. FDA for the Treatment of Advanced Soft Tissue Sarcoma". Madrid. 2014-11-25
Cambridge Crystallographic Data Centre. (11/20/14). "Press Release: Eleven More Countries Adopt Cambridge Structural Database System National Provision. Academia in 17 Countries Enjoy Unlimited Access to Cambridge Structural Database". Cambridge & Piscat 2014-11-20
Zeltia S.A.. (11/20/14). "Press Release: PharmaMar Results for Antitumoral Compounds and Their Mechanism of Action at EORTC-NCI-AACR Emphasize an Innovative Pipeline of Targeted Ttherapies". Barcelona. 2014-11-20
Almirall S.A.. (11/3/14). "Press Release: Almirall Completes Deal with AstraZeneca in Respiratory Disease". Barcelona. 2014-11-03
Scienion AG. (10/29/14). "Press Release: Collaboration between Scienion and Genomica Results in a Novel Multiplex Based Detection Kit for the Identification and Specific Differentiation of 18 Microorganisms Causing Sexual Transmitted Infections (STIs)". 2014-10-29
Almirall S.A.. (9/25/14). "Press Release: Almirall's Aclidinium Bromide/Formoterol Fumarate Recommended for Approval in Europe to Treat COPD". Barcelona. 2014-09-25
Cevec Pharmaceuticals GmbH. (9/23/14). "Press Release: Cevec Introduces CMO Services for the cGMP Manufacturing of CAP-based Clinical Materials". Cologne. 2014-09-23
Oryzon Genomics S.A.. (9/19/14). "Press Release: Oryzon Reinforces Its Board of Directors". Barcelona. 2014-09-19
Grifols S.A.. (9/19/14). "Press Release: Grifols Acquires 50% of the Share Capital of Kiro Robotics for 21 Million Euros". Barcelona. 2014-09-19
Roche. (9/17/14). "Press Release: Roche to Present Latest Oncology Advances during ESMO 2014 Congress". Basel. 2014-09-17
Grifols S.A.. (9.15.14). "Press Release: Grifols Achieves Ten Years of Research into Alzheimer's". Barcelona. 2014-09-15
Thermo Fisher Scientific Inc.. (9/3/14). "Press Release: Thermo Fisher Scientific Teams with National Reference Labs on New European Regulation, Allowing GC-MS/MS to Confirm Dioxins in Feed and Food". 2014-09-03
Bionaturis S.A.. (08/29/2014). "Press Release: Bionaturis Develops a Breakthrough Drug for Livestock". Cádiz. 2014-08-29
Era7 Bioinformatics. (08/29/2014). "Press Release: Era7 Bioinformatics Expands to U.S., Opens Office in Cambridge, Mass". Cambridge. 2014-08-29
Bionaturis S.A.. (08/29/2014). "Press Release: Andoni Cruz, BBD BioPhenix: “This New Stage with Bionaturis is a Big Opportunity to Grow in International Markets”". Cádiz. 2014-08-29
Era7 Bioinformatics. (08/29/2014). "Press Release: Era7 Bioinformatics and Comercial Rafer Announced that Rafer has Made a Strategic Investment in Era7". Granada. 2014-08-29
Zeltia S.A.. (7/23/14). "Press Release: PharmaMar Initiates a Phase I Study with Aplidin in Combination with Bortezomib and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma". Madrid. 2014-07-23
next pagenext page 1 2 3 4  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x102px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

» top